Progestin class drugs

19 results

  • Annovera

    (segesterone acetate and ethinyl estradiol)
    TherapeuticsMD, Inc.
    Usage: ANNOVERA is indicated for females of reproductive potential to prevent pregnancy. It is not adequately studied in females with a BMI greater than 29 kg/m².

  • Balcoltra

    (levonorgestrel and ethinyl estradiol)
    Avion Pharmaceuticals
    Usage: Balcoltra is indicated for females of reproductive potential for the prevention of pregnancy.

  • Climara pro

    (Estradiol and Levonorgestrel)
    Bayer HealthCare Pharmaceuticals Inc.
    Usage: Climara Pro is indicated for the treatment of moderate to severe vasomotor symptoms associated with menopause and the prevention of postmenopausal osteoporosis, specifically in women at significant risk. Non-estrogen medications should be considered first for osteoporosis prevention.

  • Kyleena

    (Levonorgestrel)
    Bayer HealthCare Pharmaceuticals Inc.
    Usage: Kyleena is indicated for the prevention of pregnancy for up to 5 years. If continued use is desired, the device should be replaced after 5 years.

  • Liletta

    (Levonorgestrel)
    Allergan, Inc.
    Usage: LILETTA is indicated for contraception to prevent pregnancy for up to 8 years and for the treatment of heavy menstrual bleeding for up to 5 years in patients using intrauterine contraception, with replacement required after 5 years if continued treatment is necessary.

  • Lo loestrin fe

    (norethindrone acetate and ethinyl estradiol, ethinyl estradiol and ferrous fumarate)
    Allergan, Inc.
    Usage: Lo Loestrin® Fe is indicated for the prevention of pregnancy in women. Its efficacy in women with a BMI greater than 35 kg/m² has not been evaluated.

  • Mirena

    (Levonorgestrel)
    Bayer HealthCare Pharmaceuticals Inc.
    Usage: Mirena is indicated for contraception, preventing pregnancy for up to 8 years, and for treating heavy menstrual bleeding for up to 5 years in women using it as their contraceptive method. Replacement is suggested at the end of the respective durations if treatment continues.

  • Myfembree

    (relugolix, estradiol hemihydrate, and norethindrone acetate)
    Sumitomo Pharma America, Inc
    Usage: MYFEMBREE is indicated for managing heavy menstrual bleeding associated with uterine leiomyomas and for treating moderate to severe pain related to endometriosis in premenopausal women. Usage is limited to 24 months due to the risk of irreversible bone loss.

  • Natazia

    (estradiol valerate and estradiol valerate/dienogest)
    Bayer HealthCare Pharmaceuticals Inc.
    Usage: Natazia® is indicated for preventing pregnancy in women and for treating heavy menstrual bleeding in those without organic pathology who prefer an oral contraceptive. Efficacy in women with a BMI over 30 kg/m² has not been evaluated.

  • Nexplanon

    (etonogestrel)
    Organon LLC
    Usage: NEXPLANON® is indicated for use in women to prevent pregnancy.